Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912221 · ClinicalTrials.gov registry record · NA
Stepping Up For Inflammatory Arthritis
A NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT02912221: Completed NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic, sponsored by University of Pennsylvania.
NCT02912221 is a NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic that has completed, run by University of Pennsylvania. The registered enrollment target is 71 participants, below the 639-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912221, a NA study of Arthritis, Rheumatoid and Arthritis, Psoriatic, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the benefits of a monitored physical activity program for participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) using a wearable activity device (e.g.fitbit). The goals of this pilot study are to examine 1) whether an incentive is better than no incentive in maintaining an increased level of physical activity and 2) the benefits of physical activity on patient reported disease activity in inflammatory arthritis.
Primary Outcome
The primary outcome will be percent of days meeting goal during the intervention period
Conditions Studied
Interventions
- OTHER Incentive
Study Locations (1)
Pennsylvania
- Hospital at the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2019-11-24 |
| Phase | NA |
What the finished NCT02912221 record still lists
NCT02912221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 639-participant average among 27 other Arthritis, Rheumatoid trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Arthritis, Rheumatoid appearing as the primary indexed condition, and to 1 intervention - of which Incentive is the first listed.
NCT02912221 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02912221 about?
NCT02912221 is a clinical study titled "Stepping Up For Inflammatory Arthritis". This study will examine the benefits of a monitored physical activity program for participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) using a wearable activity device (e.g.fitbit). The goals of this pilot study are to examine 1) whether an incentive is better than no incentive i...
What is the current status of trial NCT02912221?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2017-04-24. Estimated completion is 2019-11-24.
What conditions does trial NCT02912221 study?
This clinical trial studies the following conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic.
What interventions are being tested in trial NCT02912221?
The interventions under investigation include: Incentive (OTHER).
Who is sponsoring clinical trial NCT02912221?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02912221 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis, Rheumatoid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02912221's enrollment target sits among peer trials
71 24th of 27 higher than 4 of 27 other Arthritis, Rheumatoid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthritis, Rheumatoid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gamma Vacuum Foil (GVF) Versus Cross-linked Polyethylene in Total Knee Arthroplasty Study
COMPLETED · NA
-
Chronic Pain in Rheumatoid Arthritis
RECRUITING
-
R-2487 in Patients With Rheumatoid Arthritis
RECRUITING · Phase 1
-
IMPACT - AndHealth Autoimmune Research Registry
RECRUITING
-
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
RECRUITING · Phase 2
-
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI